CN Patent

CN104918942A — 嘧啶酮衍生物和它们用于治疗、改善或预防病毒疾病的用途

Assigned to Savira Pharmaceuticals GmbH · Expires 2015-09-16 · 11y expired

What this patent protects

本发明涉及通式(I)的化合物，其任选是药学上可接受的盐、溶剂合物、多晶型物、共用药物、共晶、前药、互变异构体、外消旋物、对映体或非对映体或其混合物的形式， 其用于治疗、改善或预防病毒疾病。此外，本发明公开了特定的组合疗法。

USPTO Abstract

本发明涉及通式(I)的化合物，其任选是药学上可接受的盐、溶剂合物、多晶型物、共用药物、共晶、前药、互变异构体、外消旋物、对映体或非对映体或其混合物的形式， 其用于治疗、改善或预防病毒疾病。此外，本发明公开了特定的组合疗法。

Drugs covered by this patent

Patent Metadata

Patent number
CN104918942A
Jurisdiction
CN
Classification
—
Expires
2015-09-16
Drug substance claim
No
Drug product claim
No
Assignee
Savira Pharmaceuticals GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.